From CEOCAST newsletter: MCLN featured.
MedClean Technologies (OTCBB: MCLN), a leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, announced it has signed a distribution agreement with Laspa Inc. Under the terms of the agreement, Laspa Inc. can now offer integrated waste stream solutions on-site at the customer location as well as provide an integrated platform for equipment and services to their existing health care customers throughout Florida. The agreement is structured so that both companies can collaborate to address the needs of the concentrated yet significant geographic territory currently covered by Laspa's business development representatives. Shares of MCLN closed unchanged from last week at $0.008.
A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO ITS OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. This publication accepts compensation from companies that it features. This newsletter should not be regarded as an independent publication. Our editors may, from time to time, acquire positions in the companies that they cover. This could represent a conflict of interest. The CEOcast newsletter shall be under no obligation to inform readers about its trading activities. CEOcast's editors reserve the right to buy or sell shares in these companies at any time. The following companies, featured in this newsletter, have compensated CEOcast: Advanced Cell Technology, seven thousand five hundred dollars per month, plus warrants to purchase up to fifteen million shares of stock; Drinks America, seven thousand five hundred dollars per month and six hundred thousand shares of stock; PHC, seven thousand five hundred dollars per month; PositiveID Corporation, seven thousand five hundred dollars per month; OmniComm, thirteen thousand six hundred and fifty dollars per month, payable in cash and common stock for a one year agreement; MedClean Technologies, seven thousand five hundred dollars per month and six million shares for a one-year agreement; Adeona Pharmaceuticals, twelve thousand five hundred dollars per month payable half in cash and half in restricted stock for a six-month agreement; Cord Blood, six thousand dollars per month and ten million shares of stock for a six-month program; Neptune Technologies & Bioresources, seven thousand five hundred dollars per month, plus fifty thousand shares of stock; Enzo Biochem, seventeen thousand dollars per month; Ceelox, fifteen thousand dollars per month in cash and stock.
